Podcast appearances and mentions of Louis J Aronne

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! Full results from the SURMOUNT-5 trial show tirzepatide (Zepbound) led to significantly greater weight loss than semaglutide 2.4 mg (Wegovy) in adults with obesity, according to findings published in The New England Journal of Medicine and presented at the 32nd European Congress on Obesity. “The SURMOUNT-5 head-to-head results demonstrated tirzepatide led to greater weight reduction compared to semaglutide, providing further evidence to support tirzepatide as an effective option for obesity management,” said principal investigator Louis J. Aronne, MD, director of the Comprehensive Weight Control Center and the Sanford I. Weill Professor of Metabolic Research at Weill Cornell Medicine, in a press release. The phase 3b trial enrolled 751 participants across 32 US and Puerto Rican sites, with 750 receiving at least one dose of study drug. Participants were randomized to their maximum tolerated dose of tirzepatide (10 mg or 15 mg) or semaglutide (1.7 mg or 2.4 mg). The primary endpoint was percent change in body weight at 72 weeks. Results showed tirzepatide produced a 20.2% average reduction in body weight versus 13.7% with semaglutide, a 6.5-point difference (P

Obesity is a physiological condition that can be managed with the right education and treatment.In today's episode, Dr. Louis J. Aronne, a leading expert in obesity research, sheds light on the science behind weight management and obesity treatment.Dr. Aronne dives into groundbreaking weight loss medications. He also explores how lifestyle and eating habits affect long-term health and why medications combined with dietary changes can unlock transformative results.Louis J. Aronne, M.D. is a leading authority on obesity and its treatment. He's a former president of The Obesity Society, which publishes the peer-reviewed scientific journal Obesity, of which Dr. Aronne is an associate editor. He has also authored more than 60 papers and book chapters on the topic. Learn how your body responds to food

⁠DozeNews PRIME⁠: as melhores e mais didáticas revisões de cardiologia direto na sua caixa de entrada! Assine agora e tenha acesso à todo material já produzido! - ⁠https://dozeporoito.substack.com/ Nesse episódio, com a ilustre presença de Eduardo Nakamura, da plataforma Endodirect, Mateus Prata e Diandro dissecam TUDO que o cardiologista precisa saber sobre o tratamento medicamentoso da obesidade: desde as diversas opções medicamentosas até o uso correto do Wegovy / Ozempic. Ainda discutimos tópicos sobre o futuro do tratamento da obesidade e o uso de substâncias termogênicas ou anfetaminérgicas para auxiliar na perda de peso. O convidado Edu é médico endocrinologista, com formação inteira pela Escola Paulista de Medicina e é sócio-fundador da plataforma Endodirect, com excelentes conteúdos no instagram e no formato podcast. ERRATA: No minuto (21:40), o estudo SCOUT foi publicado no NEJM, e não no The Lancet Minutagem: Introdução (00:00) Indicações do tratamento farmacológico (06:00) Opções e metas terapêuticas (12:30) Medicações off- label (28:00) Tempo de tratamento (32:00) Análogos GLP-1 (35:00) Manejo efeitos colaterias análogos GLP-1 (42:00) Uso off-label análogo GLP-1 e contra-indicações( 43:30) Novas terapias (49:40) Considerações finais (54:40) Referências: Caroline M. Apovian, Louis J. Aronne, Daniel H. Bessesen, Marie E. McDonnell, M. Hassan Murad, Uberto Pagotto, Donna H. Ryan, Christopher D. Still, Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, Volume 100, Issue 2, 1 February 2015, Pages 342–362, https://doi.org/10.1210/jc.2014-3415 ASSOCIAÇÃO BRASILEIRA PARA O ESTUDO DA OBESIDADE E DA SÍNDROME METABÓLICA. Diretrizes brasileiras de obesidade. 4. ed. São Paulo: ABESO, 2016.

Today, you'll learn about a new drug that could help you safely lose up to a fifth of your body weight, a new, non-hormonal birth control pill that is made for men, and how drones may hold the key to reforestation.Weight loss five times faster.“Diabetes drug helps patients lose never-before-seen amounts of weight, study shows” by Karen Weintraubhttps://www.usatoday.com/story/news/health/2022/06/04/diabetes-drug-could-game-changer-obesity-new-study-shows/7490446001/“Tirzepatide Once Weekly for the Treatment of Obesity” by Ania M. Jastreboff, M.D., Ph.D., Louis J. Aronne, M.D., Nadia N. Ahmad, M.D., M.P.H., Sean Wharton, M.D., Pharm.D., Lisa Connery, M.D., Breno Alves, M.D., Arihiro Kiyosue, M.D., Ph.D., Shuyu Zhang, M.S., Bing Liu, Ph.D., Mathijs C. Bunck, M.D., Ph.D., and Adam Stefanski, M.D., Ph.D.https://www.nejm.org/doi/full/10.1056/NEJMoa2206038?query=featured_homeMen entering the world of birth control.“This birth control pill for men could begin human trials later this year” by Hannah Seohttps://www.popsci.com/health/new-male-birth-control-pill/“A non-hormonal pill could soon expand men's birth control options” by The American Chemical Societyhttps://www.acs.org/content/acs/en/pressroom/newsreleases/2022/march/non-hormonal-pill-could-soon-expand-mens-birth-control-options.html“Male Birth Control Pill Expected to Start Human Trials This Year” by corryn Wetzelhttps://www.smithsonianmag.com/smart-news/male-birth-control-pill-expected-to-start-human-trials-this-year-180979814/“Contraceptive Use” by the CDChttps://www.cdc.gov/nchs/fastats/contraceptive.htmSeed bombing may not be what you think.“Drones Are Setting Down Roots In Wildfire-Scarred Landscapes” by  Ashley Franzenhttps://www.theverge.com/23022323/drones-wildfire-first-nation-british-columbia“Aerial Planting: Bc First Nations Company Trialing Reforestation With Drones” by Maria Churchhttps://www.woodbusiness.ca/aerial-planting-reforestation-drones/Follow Curiosity Daily on your favorite podcast app to get smarter with Calli and Nate — for free! Still curious? Get exclusive science shows, nature documentaries, and more real-life entertainment on discovery+! Go to https://discoveryplus.com/curiosity to start your 7-day free trial. discovery+ is currently only available for US subscribers.Find episode transcripts here: https://curiosity-daily-4e53644e.simplecast.com/episodes/wait-less-weight-loss-birth-control-for-men-seed-bombing

  On PopHealth Week, our guests are Weill Cornell Medicine faculty: Dr. Louis Aronne and Dr. Katherine Saunders, co-founders of Intellihealth, a company fighting the global obesity epidemic. They also host the podcast Weight Matters. Louis J. Aronne, MD, FACP is the Director, Comprehensive Weight Control Center,Weill Cornell Medicine and Past Chairman, American Board of Obesity Medicine. Katherine H. Saunders, MD, DABOM is an Assistant Professor of Clinical Medicine at Weill Cornell Medicine and an Assistant Attending Physician at New York-Presbyterian Hospital. Do follow their work on Twitter via @ljaronne and @Intellihealth1 and on the web at Comptehensive Weight Control Center or atIntellihealth. ==##==  

On PopHealth Week, our guests are Weill Cornell Medicine faculty: Dr. Louis Aronne and Dr. Katherine Saunders, co-founders of Intellihealth, a company fighting the global obesity epidemic. They also host the podcast Weight Matters. Louis J. Aronne, MD, FACP is the Director, Comprehensive Weight Control Center, Weill Cornell Medicine and Past Chairman, American Board of Obesity Medicine. Katherine H. Saunders, MD, DABOM is an Assistant Professor of Clinical Medicine at Weill Cornell Medicine and an Assistant Attending Physician at New York-Presbyterian Hospital. Do follow their work on Twitter via @ljaronne and @Intellihealth1 and on the web at Comptehensive Weight Control Center or at Intellihealth. ==##==

Dr. Louis Aronne, MD, FACP, Chief Medical Officer of Intellihealth and medical director of the Comprehensive Weight Control Center at Weill Cornell, discusses the latest medical obesity treatment: Intellihealth’s Evolve -- a technology platform for medically-supervised weight management. Louis J. Aronne, MD, FACP is a leading authority on obesity and its treatment. He is the Sanford I. Weill Professor of Metabolic Research at Weill-Cornell Medical College and directs the Center for Weight Management and Metabolic Clinical Research, a state-of-the-art, multidisciplinary obesity research and treatment program. He has an adjunct appointment at Columbia University College of Physicians and Surgeons. Dr. Aronne is Founder and CEO of BMIQ, a weight control program that is delivered by health care providers to their patients during office visits. Dr. Aronne graduated Phi Beta Kappa from Trinity College with a BS in biochemistry and from Johns Hopkins University School of Medicine. He completed his internship and residency at Albert Einstein College of Medicine and the Bronx Municipal Hospital Center, followed by a Henry J. Kaiser Family Foundation Fellowship at New York Hospital-Cornell Medical Center. He is a member of the Alpha Omega Alpha Medical Honor Society. Dr. Aronne is former president of the Obesity Society and a Fellow of the American College of Physicians. Vice-chairman of the board of the American Board of Obesity Medicine, he has authored more than 60 papers and book chapters on obesity and edited the National Institutes of Health Practical Guide to the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. He served as a consultant to the VA Weight Management/Physical Activity Executive Council in the development of the MOVE program, the nation’s largest medically based weight control program. Dr. Aronne has won several awards for medical teaching, including the Davidoff Prize from Albert Einstein College of Medicine and the Elliot Hochstein Award from Cornell University.

Get FREE LOVE Cafe Newsletter Here Friend LOVE Cafe on FaceBook Here Scott Cluthe interviews Louis J Aronne, the MD for the Davie Letterman Show and Best Selling author. Dr. Aronne's new book is titled, The Change Your Biology Diet, from Hougton Mifflin Harcourt Publishing. LIVE Moday at 7 PM EST-6 CST - 5 MSt - 4 PST Call in: 347-308-8478  A best-selling doctor’s life-changing program and diet plan to effectively overcome addictions to sugar, fat, and salt, and achieve permanent weight loss Louis J. Aronne, M.D., an internationally recognized weight-management expert and the director of the Comprehensive Weight Control Center at Weill-Cornell Medical College, has created the Change Your Biology Diet, a proven program that helps people break through weight loss “resistance” to drop excess pounds and keep them off. Dr. Aronne’s approach, unlike fad diets, focuses on biological factors that cause weight gain. Following his plan can reverse this process. With the support of his extensive knowledge and the latest research, readers learn Twelve Breakthrough Strategies for Successful Weight Management, such as how the order in which food is eaten affects weight loss. He provides two different adaptable diets so that readers can personalize a program that works for them. Dr. Aronne covers the most recent developments in weight loss medications and bariatric procedures. The Change Your Biology Diet provides readers with everything they need to know to lose weight successfully from one of the pioneers in the field of obesity medicine.

Louis J. Aronne, M.D.